← Leaderboards
Robert H Mach
Wake Forest University
$43,288,677
Attributed
$43,288,677
Total exposure
39
Grants
33
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $11.4M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$84,901,780 · 41
By mechanism
U19$54,161,281 · 14
P30$14,594,620 · 4
R01$6,465,792 · 5
R21$4,405,928 · 6
R33$2,503,726 · 2
P01$1,650,262 · 1
Top collaborators
- Henry Richard Kranzler6 shared
Others in their field
Top investigators on “Radiotracer”
- Simon R Cherry · University Of California Los Angeles$17,948,135
- Joel Synes Perlmutter · Washington University$16,457,601
- Gwenn S Smith · Long Island Jewish Medical Center$16,008,680
- Richard E Carson · Yale University$15,174,693
- Rajesh Narendran · Columbia University Health Sciences$15,115,382
- Yiyun Henry Huang · Yale University$14,727,720
Research focus
RadiotracerImagePositron-Emission TomographyResearch PersonnelRadiochemistryResearch Project GrantsLigandsProgramsBaseBrainIn VivoFundingImaging StudyLeadStructure-Activity RelationshipUniversitiesResourcesIn VitroParkinson DiseaseMemberAffinityRadiolabeledSeriesAlzheimer&Apos
Grant awards (115)
Center without Walls for Imaging Proteinopathies with PET$5,910,871
U19 · FY2025 · NS · contact PI
Medicinal Chemistry and Radiochemistry Core$1,647,679
U19 · FY2025 · NS · contact PI
In Vitro and In Vivo Characterization of Alpha-Synuclein PET Radiotracers$1,183,686
U19 · FY2025 · NS · contact PI
Administrative Core$431,567
U19 · FY2025 · NS · contact PI
Center without Walls for Imaging Proteinopathies with PET$6,037,524
U19 · FY2024 · NS · contact PI
Medicinal Chemistry and Radiochemistry Core$1,678,882
U19 · FY2024 · NS · contact PI
In Vitro and In Vivo Characterization of Alpha-Synuclein PET Radiotracers$1,214,937
U19 · FY2024 · NS · contact PI
Administrative Core$431,567
U19 · FY2024 · NS · contact PI
Center without Walls for Imaging Proteinopathies with PET (CW2IP2)$3,974,587
U19 · FY2023 · NS · contact PI
Penn PET Addiction Center of Excellence (Penn PACE)$1,818,556
P30 · FY2023 · DA · contact PI
Medicinal Chemistry Core$1,315,999
U19 · FY2023 · NS · contact PI
In Vitro and In Vivo Characterization of Alpha-Synuclein PET Radiotracers$855,716
U19 · FY2023 · NS · contact PI
Radiochemistry Core$419,539
P30 · FY2023 · DA · contact PI
Administrative Core$408,383
U19 · FY2023 · NS · contact PI
Penn PET Addiction Center of Excellence (PACE)$405,997
P30 · FY2023 · DA · contact PI
Administrative Core$243,375
P30 · FY2023 · DA · contact PI
Center without Walls for Imaging Proteinopathies with PET (CW2IP2)$4,155,123
U19 · FY2022 · NS · contact PI
Penn PET Addiction Center of Excellence (Penn PACE)$1,843,247
P30 · FY2022 · DA · contact PI
Medicinal Chemistry Core$1,404,681
U19 · FY2022 · NS · contact PI
In Vitro and In Vivo Characterization of Alpha-Synuclein PET Radiotracers$856,001
U19 · FY2022 · NS · contact PI
Radiochemistry Core$419,539
P30 · FY2022 · DA · contact PI
Administrative Core$409,454
U19 · FY2022 · NS · contact PI
Administrative Core$243,375
P30 · FY2022 · DA · contact PI
Center without Walls for Imaging Proteinopathies with PET (CW2IP2)$100,000
U19 · FY2022 · NS · contact PI
Center without Walls for Imaging Proteinopathies with PET (CW2IP2)$4,279,279
U19 · FY2021 · NS · contact PI
Penn PET Addiction Center of Excellence (Penn PACE)$1,846,343
P30 · FY2021 · DA · contact PI
Medicinal Chemistry Core$1,661,993
U19 · FY2021 · NS · contact PI
In Vitro and In Vivo Characterization of Alpha-Synuclein PET Radiotracers$1,045,739
U19 · FY2021 · NS · contact PI
Administrative Core$411,397
U19 · FY2021 · NS · contact PI
Radiochemistry Core$369,269
P30 · FY2021 · DA · contact PI
Administrative Core$369,269
P30 · FY2021 · DA · contact PI
Center without Walls for Imaging Proteinopathies with PET (CW2IP2)$4,203,503
U19 · FY2020 · NS · contact PI
Medicinal Chemistry Core$1,759,916
U19 · FY2020 · NS · contact PI
Penn PET Addiction Center of Excellence (Penn PACE)$1,701,466
P30 · FY2020 · DA · contact PI
In Vitro and In Vivo Characterization of Alpha-Synuclein PET Radiotracers$1,069,406
U19 · FY2020 · NS · contact PI
Radiochemistry Core$623,432
P30 · FY2020 · DA · contact PI
PET Radiotracers for Imaging the Dopamine D3 Receptor$485,428
R01 · FY2020 · DA · contact PI
Administrative Core$436,782
U19 · FY2020 · NS · contact PI
Administrative Core$308,411
P30 · FY2020 · DA · contact PI
ConProject-004$215,450
U19 · FY2020 · NS · contact PI
ConProject-005$172,222
U19 · FY2020 · NS · contact PI
ConProject-002$171,046
U19 · FY2020 · NS · contact PI
ConProject-007$162,291
U19 · FY2020 · NS · contact PI
ConProject-008$51,271
U19 · FY2020 · NS · contact PI
ConProject-006$32,083
U19 · FY2020 · NS · contact PI
ConProject-009$10,415
U19 · FY2020 · NS · contact PI
Center without Walls for Imaging Proteinopathies with PET (CW2IP2)$3,573,953
U19 · FY2019 · NS · contact PI
Penn PET Addiction Center of Excellence (Penn PACE)$1,762,654
P30 · FY2019 · DA · contact PI
Medicinal Chemistry Core$1,479,035
U19 · FY2019 · NS · contact PI
In Vitro and In Vivo Characterization of Alpha-Synuclein PET Radiotracers$1,017,122
U19 · FY2019 · NS · contact PI
PET Radiotracers for Imaging the Dopamine D3 Receptor$556,506
R01 · FY2019 · DA · contact PI
Imaging the D2/A2A Heterodimer with PET$447,276
R01 · FY2019 · EB · contact PI
Radiochemistry Core$446,796
P30 · FY2019 · DA · contact PI
Administrative Core$391,721
U19 · FY2019 · NS · contact PI
Administrative Core$242,626
P30 · FY2019 · DA · contact PI
Imaging oxidative stress in an animal model of AD with PET$201,250
R21 · FY2019 · AG · contact PI
PET Radiotracers for Imaging the Dopamine D3 Receptor$521,609
R01 · FY2018 · DA · contact PI
Imaging the D2/A2A Heterodimer with PET$447,276
R01 · FY2018 · EB · contact PI
Imaging oxidative stress in an animal model of AD with PET$241,500
R21 · FY2018 · AG · contact PI
PET Radiotracers for Imaging the Dopamine D3 Receptor$526,913
R01 · FY2017 · DA · contact PI
PET Radiotracers for Imaging the Dopamine D3 Receptor$598,375
R01 · FY2016 · DA · contact PI
PET RADIOTRACERS FOR IMAGING THE DOPAMINE D3 RECEPTOR$338,932
R01 · FY2014 · DA · contact PI
PET RADIOTRACERS FOR IMAGING THE DOPAMINE D3 RECEPTOR$325,549
R01 · FY2013 · DA · contact PI
PET RADIOTRACERS FOR IMAGING THE DOPAMINE D3 RECEPTOR$335,989
R01 · FY2012 · DA · contact PI
Dopamine D2 Selective Imaging Agents$396,534
R33 · FY2011 · MH · contact PI
PET RADIOTRACERS FOR IMAGING THE DOPAMINE D3 RECEPTOR$335,989
R01 · FY2011 · DA · contact PI
DEVELOPMENT OF IMAGE ENHANCEMENT RADIOPHARMACEUTICALS FOR THERAPY$3,604
P41 · FY2011 · RR · contact PI
PET BRAIN IMAGING OF REACTIVE OXYGEN SPECIES$495,848
RC1 · FY2010 · AG · contact PI
Dopamine D2 Selective Imaging Agents$427,912
R33 · FY2010 · MH · contact PI
PET RADIOTRACERS FOR IMAGING THE DOPAMINE D3 RECEPTOR$295,375
R01 · FY2010 · DA · contact PI
DEVELOPMENT OF IMAGE ENHANCEMENT RADIOPHARMACEUTICALS FOR THERAPY$4,079
P41 · FY2010 · RR · contact PI
PET BRAIN IMAGING OF REACTIVE OXYGEN SPECIES$499,024
RC1 · FY2009 · AG · contact PI
Dopamine D2 Selective Imaging Agents$415,160
R33 · FY2009 · MH · contact PI
Vascular and Metabolic Mechanisms in Alzheimer's Disease$106,300
R01 · FY2009 · AG · contact PI
DEVELOPMENT OF IMAGE ENHANCEMENT RADIOPHARMACEUTICALS FOR THERAPY$1,741
P41 · FY2009 · RR · contact PI
Chemistry Studies$455,677
P01 · FY2008 · HL · contact PI
Core--Radiochemistry$295,431
P30 · FY2008 · NS · contact PI
Radiolabeled Probes for Imaging Caspase 3 Activation$284,645
R21 · FY2008 · CA · contact PI
Dopamine D2 Selective Imaging Agents$202,050
R21 · FY2008 · MH · contact PI
Vascular and Metabolic Mechanisms in Alzheimer's Disease$103,203
R01 · FY2008 · AG · contact PI
DEVELOPMENT OF IMAGE ENHANCEMENT RADIOPHARMACEUTICALS FOR THERAPY$1,073
P41 · FY2008 · RR · contact PI
Chemistry Studies$453,180
P01 · FY2007 · HL · contact PI
Core--Radiochemistry$330,014
P30 · FY2007 · NS · contact PI
Radiolabeled Probes for Imaging Caspase 3 Activation$284,645
R21 · FY2007 · CA · contact PI
Dopamine D2 Selective Imaging Agents$215,050
R21 · FY2007 · MH · contact PI
Vascular and Metabolic Mechanisms in Alzheimer's Disease$102,271
R01 · FY2007 · AG · contact PI
DEVELOPMENT OF IMAGE ENHANCEMENT RADIOPHARMACEUTICALS FOR THERAPY$4,067
P41 · FY2007 · RR · contact PI
Dopamine D3 Receptor Imaging Agents for PET and SPECT$490,956
R21 · FY2006 · DA · contact PI
PET Imaging of Breast Cancer via Sigma-2 Receptors$488,484
R33 · FY2006 · CA · contact PI
Radiolabeled Probes for Imaging Caspase 3 Activation$293,949
R21 · FY2006 · CA · contact PI
Chemistry Studies$288,009
P01 · FY2006 · HL · contact PI
Core--Radiochemistry$284,274
P30 · FY2006 · NS · contact PI
Vascular and Metabolic Mechanisms in Alzheimer's Disease$102,594
R01 · FY2006 · AG · contact PI
DEVELOPMENT OF IMAGE ENHANCEMENT RADIOPHARMACEUTICALS FOR THERAPY$2,758
P41 · FY2006 · RR · contact PI
PET Imaging of Breast Cancer via Sigma-2 Receptors$392,273
R33 · FY2005 · CA
Dopamine D3 Receptor Imaging Agents for PET and SPECT$383,411
R21 · FY2005 · DA
Radiolabeled Probes for Imaging Caspase 3 Activation$302,010
R21 · FY2005 · CA
Core--Radiochemistry$297,333
P30 · FY2005 · NS
Chemistry Studies$237,518
P01 · FY2005 · HL
PET Imaging of Breast Cancer via Sigma-2 Receptors$383,363
R33 · FY2004 · CA
Dopamine D3 Receptor Imaging Agents for PET and SPECT$377,781
R21 · FY2004 · DA
Core--Radiochemistry$323,674
P30 · FY2004 · NS
PET Radiotracers for Imaging Apoptosis$229,500
R21 · FY2004 · EB
Chemistry Studies$215,878
P01 · FY2004 · HL
SYNTHESIS OF PET IMAGING AGENTS$2,977
P41 · FY2004 · RR
Dopamine D3 Receptor Imaging Agents for PET and SPECT$265,179
R21 · FY2003 · DA
PET Radiotracers for Imaging Apoptosis$229,500
R21 · FY2003 · EB
PET Imaging of Breast Cancer via Sigma-2 Receptors$191,730
R21 · FY2003 · CA
Dopamine D3 Receptor Imaging Agents for PET and SPECT$29,796
R21 · FY2003 · DA
DEVELOPMENT OF D3 ANTAGONISTS TO TREAT COCAINE ADDICTION$272,942
R01 · FY2002 · DA
Dopamine D3 Receptor Imaging Agents for PET and SPECT$182,976
R21 · FY2002 · DA
DEVELOPMENT OF D3 ANTAGONISTS TO TREAT COCAINE ADDICTION$249,802
R01 · FY2001 · DA
DEVELOPMENT OF D3 ANTAGONISTS TO TREAT COCAINE ADDICTION$262,742
R01 · FY2000 · DA
SIGMA 1 RECEPTOR PROBES FOR IMAGING TUMOR PROLIFERATION$105,000
R41 · FY2000 · CA
PET IMAGING STUDIES OF A RHESUS MONKEY MODEL OF AGING$50,721
R01 · FY2000 · AG